Drugs Made In America Acquisition II Corp. Unit (DMIIU) Stock Price
DMIIUStock
$10.20
Market Cap—
P/E77.06x
PEG Ratio—
Div yield—
Beta0.02
DMIIU Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-9.99%
Price vs S&P 500 (4W)-4.40%
VGM Score52.61
P/E Ratio (Annual)77.06x
Industry Peers — Blank Checks / SPACs(909)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | C | $10.20 |
| BXBLBOXABL, Inc. Common stock | C | B | D | $4.27 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.15 |
| CXIIChurchill Capital Corp XII Class A Ordinary Shares | — | — | F | $10.82 |
| BCSSBain Capital GSS Investment Corp. | — | — | B | $10.28 |
| EVACEQV Ventures Acquisition Corp. II | — | — | B | $10.27 |
| CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | — | — | D | $10.38 |
| AEXAAmerican Exceptionalism Acquisition Corp. A | — | — | B | $11.49 |
| DBCAD. Boral Acquisition I Corp. Class A Ordinary Shares | — | — | D | $10.00 |
| GHXIGores Holdings XI, Inc. Class A Ordinary Shares | — | — | D | $10.04 |
| RFAIURF Acquisition Corp II Unit | D | F | A | $52.94 |
About Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp is a special purpose acquisition company (SPAC) seeking to combine with an operating company in the pharmaceutical industry. The company provides capital and a path to public markets for qualified acquisition targets in the U.S. pharmaceutical sector.